SCHEMBL1379674

SCHEMBL1379674

Cc1ccc(Oc2cnc(N)nc2N[C@H]2CC[C@H](O)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.41
MERTK Q12866 7/20 0.40
TYRO3 Q06418 5/20 0.40
FLT3 P36888 4/20 0.40
GAS6 Q14393 4/20 0.40
AXL P30530 3/20 0.38
CHUK O15111 1/20 0.38
LCK P06239 2/20 0.38
EGFR P00533 1/20 0.38
INSR P06213 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
MAPKAPK2 P49137 1/20 0.37
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
SYK P43405 3/20 0.36
ITK Q08881 1/20 0.36
AURKB Q96GD4 1/20 0.36
CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379676 1.00 BTK (0.41) BTKMERTKTYRO3FLT3GAS6
SCHEMBL1379021 0.91 MAPT (0.44) BTKMERTKTYRO3FLT3GAS6
SCHEMBL1379026 0.91 MAPT (0.44) BTKMERTKTYRO3FLT3GAS6
SCHEMBL1376243 0.88 BTK (0.40) BTKMERTKTYRO3FLT3GAS6
SCHEMBL1376242 0.88 BTK (0.40) BTKMERTKTYRO3FLT3GAS6
SCHEMBL5204420 0.88 LCK (0.46) BTKMERTKTYRO3FLT3GAS6
SCHEMBL5204412 0.88 LCK (0.46) BTKMERTKTYRO3FLT3GAS6
SCHEMBL5203150 0.88 BTK (0.40) BTKMERTKTYRO3FLT3GAS6
SCHEMBL7157240 0.88 BTK (0.39) BTKMERTKTYRO3FLT3GAS6
SCHEMBL7157245 0.88 BTK (0.39) BTKMERTKTYRO3FLT3GAS6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4743463-B2 2011-08-10 JP claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
JP-2002541245-A 2002-12-03 JP claimed
EP-1165523-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES Krenitsky Pharmaceuticals, Inc. (US) 2002-01-02 EP claimed
WO-2000061562-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC. (US) 2000-10-19 WO claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed
EP-1165523-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES Krenitsky Pharmaceuticals, Inc. (US) 2002-01-02 EP disclosed
WO-2000061562-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC. (US) 2000-10-19 WO disclosed